Title:
COMBINATION THERAPIES FOR THE TREATMENT OF OBESITY
Document Type and Number:
WIPO Patent Application WO/2010/045529
Kind Code:
A3
Abstract:
Described are pharmaceutical compositions comprising diethylpropion, metformin, orlistat, and at least one pharmaceutically acceptable carrier or excipient. Another aspect of the present invention relates to a method of treating a patient suffering from obesity or needing to lose weight, comprising the step of co-administering to said patient a therapeutically effective amount of diethylpropion, metformin, and orlistat. In certain embodiments, an aforementioned method is practiced in conjunction or tandem with a medical procedure or the use of a medical device or both.
More Like This:
Inventors:
ARONNE LOUIS J (US)
Application Number:
PCT/US2009/060953
Publication Date:
August 12, 2010
Filing Date:
October 16, 2009
Export Citation:
Assignee:
METABOLOUS PHARMACEUTICALS INC (US)
ARONNE LOUIS J (US)
ARONNE LOUIS J (US)
International Classes:
A61K31/135; A61K31/155; A61K31/365; A61P3/04
Foreign References:
| US20070244130A1 | 2007-10-18 | |||
| US7115640B2 | 2006-10-03 | |||
| US20040204472A1 | 2004-10-14 | |||
| US20070060532A1 | 2007-03-15 | |||
| US6686337B2 | 2004-02-03 |
Other References:
KLONOFF D.C. ET AL.: "Drugs in the Pipeline for the Obesity Market", JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, vol. 2, no. 5, September 2008 (2008-09-01), pages 913 - 918
Attorney, Agent or Firm:
GORDON, Dana, M. et al. (Seaport World Trade Center West155 Seaport Blvd, Boston MA, US)
Download PDF: